中国实用外科杂志2017，Vol.37Issue(8)：853-860,8.DOI:10.19538/j.cjps.issn1005-2208.2017.08.07
ERCP术后胰腺炎的预防策略
Prevention strategies of post-endoscopic retrograde cholangiopancreatography pancreatitis
郭学刚 1罗辉 1郑亮1
作者信息
- 1. 第四军医大学西京消化病医院内镜中心,陕西西安 710032
- 折叠
摘要
Abstract
Pancreatitis is the most common and serious com-plication of endoscopic retrograde cholangiopancreatography (ERCP). Rectal non-steroidal antiinflammatory drugs (NSAIDs) (indomethacin or diclofenac) and pancreatic stents are effective preventions of post-ERCP pancreatitis. Optimal ERCP perioperative management (preoperative risk evalua- tion, intraoperative risk management, postoperative active treatment) can reduce PEP risk effectively.关键词
内镜逆行胰胆管造影/胰腺炎/非甾体抗炎药/支架Key words
endoscopic retrograde cholangiopancreatography/pancreatitis/non-steroidal antiinflammatory drugs/stent分类
医药卫生引用本文复制引用
郭学刚,罗辉,郑亮..ERCP术后胰腺炎的预防策略[J].中国实用外科杂志,2017,37(8):853-860,8.
